Context: The world's first vaccine for chikungunya was recently approved by the Food and Drug Administration (FDA) in the U.S.
Chikungunya
About: Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV), an RNA virus in the alphavirus genus of the family Togaviridae.
Name Origin: The name chikungunya derives from a word in the Kimakonde language, meaning “to become contorted”.
Distribution: CHIKV was first identified in the United Republic of Tanzania in 1952 and subsequently in other countries Africa and Asia.
Outbreaks: Urban outbreaks were first recorded in Thailand in 1967 and in India in the 1970s.
CHIKV has now been identified in over 110 countries in Asia, Africa, Europe and the Americas.
Transmission: By mosquitoes, most commonly Aedes (Stegomyia) aegypti and Aedes (Stegomyia) albopictus, which can also transmit dengue and Zika viruses.
Symptoms: CHIKV disease onset is typically 4–8 days (range 2–12 days) after the bite of an infected mosquito.
Fever, frequently accompanied by severe joint pain, muscle pain, headache, nausea, fatigue and rash.
Treatment: There is no specific antiviral drug treatment for CHIKV infections.